[Davis, M.E. (2009). The first targeted delivery of siRNA in humans via a self-assembling, cyclodextrin polymer-based nanoparticle: From concept to clinic, Molecular Pharmacology 6(3): 659-668.10.1021/mp900015y19267452]Search in Google Scholar
[Dorsett, Y. and Tuschl, T. (2009). siRNAs: Applications in functional genomics and potential as therapeutics, Nature Reviews Drug Discovery 3(4): 318-329.10.1038/nrd134515060527]Search in Google Scholar
[Fire, A., Xu, S., Montgomery, M., Kostas, S., Driver, S. and Mello, C. (1998). Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans, Nature 391(6669): 806-811.10.1038/358889486653]Search in Google Scholar
[Fujarewicz, K. (2010). Planning identification experiments for cell signaling pathways: An NFκB case study, International Journal of Applied Mathematics and Computer Science 20(4): 773-780, DOI: 10.2478/v10006-010-0059-6.10.2478/v10006-010-0059-6]Search in Google Scholar
[García, J., Silva, J., Pen˜a, C., Garcia, V., Rodr´ıguez, R., Cruz, M.A., Cantos, B., Provencio, M., Espan˜a, P. and Bonilla, F. (2004). Promoter methylation of the PTEN gene is a common molecular change in breast cancer, Genes Chromosomes and Cancer 41(2): 117-124.10.1002/gcc.2006215287024]Search in Google Scholar
[Gatter, K., Brown, G., Trowbridge, I., Woolston, R. and Mason, D. (1983). Transferring receptors in human tissues: Their distribution and possible clinical relevance, Journal of Clinical Pathology 36(5): 539-545.10.1136/jcp.36.5.5394982836302135]Search in Google Scholar
[Geva-Zatorsky, N., Rosenfeld, N., Itzkovitz, S., Milo, R., Sigal, A., Dekel, E., Yarnitzky, T., Liron, Y., Polak, P., Lahav, G. and Alon, U. (2006). Oscillations and variability in the p53 system, Molecular Systems Biology 2: 2006.0033.]Search in Google Scholar
[Giono, L. and Manfredi, J. (2007). Mdm2 is required for inhibition of cdk2 activity by p21, thereby contributing to p53-dependent cell cycle arrest, Molecular Cell Biology 27(11): 4166-4178.10.1128/MCB.01967-06190001917371838]Search in Google Scholar
[Goldstein, I., Marcel, V., Olivier, M., Oren, M., Rotter, V. and Hainaut, P. (2011). Understanding wild-type and mutant p53 activities in human cancer: New landmarks on the way to targeted therapies, Cancer Gene Therapy 18(1): 2-11.10.1038/cgt.2010.6320966976]Search in Google Scholar
[Hannon, G. and Rossi, J. (2004). Unlocking the potential of the human genome with RNA interference, Nature 431(7006): 371-378.10.1038/nature0287015372045]Search in Google Scholar
[Harris, S. and Levine, A. (2005). The p53 pathway: Positive and negative feedback loops, Oncogene 24(17): 2899-2908.10.1038/sj.onc.120861515838523]Search in Google Scholar
[Haupt, Y., Maya, R., Kazaz, A. and Oren, M. (1997). Mdm2 promotes the rapid degradation of p53, Nature 387(6630): 296-299.10.1038/387296a0]Search in Google Scholar
[Hrstka, R., Coates, P. and Vojtesek, B. (2009). Polymorphisms in p53 and the p53 pathway: Roles in cancer susceptibility and response to treatment, Journal of Cellular and Molecular Medicine 13(3): 440-453.10.1111/j.1582-4934.2008.00634.x]Search in Google Scholar
[Kim, B., Tang, Q., Biswas, P., Xu, J., Schiffelers, R., Xie, F., Ansari, A., Scaria, P., Woodle, M., Lu, P. and Rouse, B. (2004). Inhibition of ocular angiogenesis by siRNA targeting vascular endothelial growth factor pathway genes: Therapeutic strategy for herpetic stromal keratitis, The American Journal of Pathology 165(6): 2177-2185.10.1016/S0002-9440(10)63267-1]Search in Google Scholar
[Kohn, K. and Pommier, Y. (2005). Molecular interaction map of the p53 and mdm2 logic elements, which control the off-on switch of p53 in response to DNA damage, Biochemical and Biophysical Research Communications 331(3): 816-827.10.1016/j.bbrc.2005.03.18615865937]Search in Google Scholar
[Krawczyk, B., Rudnicka, K. and Fabianowska-Majewska, K. (2007). The effects of nucleoside analogues on promoter methylation of selected tumor suppressor genes in mcf-7 and mda-mb-231 breast cancer cell lines, Nucleosides, Nu-cleotides and Nucleic Acids 26(8-9): 1043-1046.10.1080/1525777070150959418058533]Search in Google Scholar
[Levine, A., Hu, W. and Feng, Z. (2006). The p53 pathway: What questions remain to be explored?, Cell Death and Differentiation 13(6): 1027-1036.10.1038/sj.cdd.440191016557269]Search in Google Scholar
[Li, L. and Ross, A. (2007). Why is PTEN an important tumor suppressor?, Journal of Cellular Biochemistry 102(6): 1368-1374.10.1002/jcb.2159317972252]Search in Google Scholar
[Li, W. and Cha, L. (2007). Predicting siRNA efficiency, Cellular and Molecular Life Sciences 64(14): 1785-11792.10.1007/s00018-007-7057-3707979017415516]Search in Google Scholar
[Makinen, P., Koponen, J., Karkkainen, A., Malm, T., Pulkkinen, K., Koistinaho, J., Turunen, M. and Yla-Herttuala, S. (2006). Stable RNA interference: Comparison of u6 and h1 promoters in endothelial cells and in mouse brain, The Journal of Gene Medicine 8(4): 433-441.10.1002/jgm.86016389634]Search in Google Scholar
[Overhoff, M., Wnsche, W. and Sczakiel, G. (2004). Quantitative detection of siRNA and single-stranded oligonucleotides: Relationship between uptake and biological activity of siRNA, Nucleic Acids Research 32(21): e170.10.1093/nar/gnh16853569715576677]Search in Google Scholar
[Puszynski, K., Hat, B. and Lipniacki, T. (2008). Oscillations and bistability in the stochastic model of p53 regulation, Journal of Theoretical Biology 254(2): 452-465.10.1016/j.jtbi.2008.05.03918577387]Search in Google Scholar
[Ryther, R., Flynt, A., Phillips, J. and Patton, J. (2005). siRNA therapeutics: Big potential from small RNAs, Gene Therapy 12(1): 5-11.10.1038/sj.gt.330235615496962]Search in Google Scholar
[Shim, M. and Kwon, Y. (2010). Efficient and targeted delivery of siRNA in vivo, FEBS Journal 277(23): 4814-4827.10.1111/j.1742-4658.2010.07904.x21078116]Search in Google Scholar
[Świerniak, A., Ledzewicz, U. and Scha¨ttler, H. (2003). Optimal control for a class of compartmental models in cancer chemotherapy, International Journal of Applied Mathematics and Computer Since 13(3): 357-368.]Search in Google Scholar
[Veldhoen, S., Laufer, S.D., Trampe, A. and Restle, T. (2006). Cellular delivery of small interfering RNA by a non-covalently attached cell-penetrating peptide: Quantitative analysis of uptake and biological effect, Nucleic Acids Research 34(22): 6561-6573.10.1093/nar/gkl941174718317135188]Search in Google Scholar